{% extends "layout.html" %}

{% block title %}Diversity & Inclusivity{% endblock %}

{% block page_content %}

<style>
    .slide--1__darkbg {
        left: 0%;
        background: url("https://static.igem.wiki/teams/4636/wiki/proposed-implementation.jpg") center center no-repeat;
        background-size: cover;
        background-position: 0px center, 0px center;
        transform: translate3d(0, 0, 0);
        will-change: transform;
    }

    .slide--1__letter {
        background: url("https://static.igem.wiki/teams/4636/wiki/proposed-implementation.jpg") center center no-repeat;
        background-position: 0px center, 0px center;
        background-size: cover;
    }
</style>
<script src="{{ url_for('static', filename = 'banner-container.js') }}"></script>
<script>
    $(document).ready(function () {
        const $cont = $('.cont');
        const $slider = $('.slider');
        const $nav = $('.nav');
        const winW = $(window).width();
        const animSpd = 750; // Change also in CSS
        const distOfLetGo = winW * 0.2;
        let curSlide = 1;
        let animation = false;
        let autoScrollVar = false;
        let diff = 0;

        // Generating slides
        let arrCities = ['Propose', 'Problem', 'Inspiration', 'Our goal', 'Advantages']; // Change number of slides in CSS also
        let numOfCities = arrCities.length;
        let arrCitiesDivided = [];

        arrCities.map((city) => {
            let length = city.length;
            let letters = Math.floor(length / 4);
            let exp = new RegExp(".{1," + letters + "}", "g");

            arrCitiesDivided.push(city.match(exp));
        });

        let generateSlide = function (city) {
            let frag1 = $(document.createDocumentFragment());
            let frag2 = $(document.createDocumentFragment());
            const numSlide = arrCities.indexOf(arrCities[city]) + 1;
            const firstLetter = arrCitiesDivided[city][0].charAt(0);

            const $slide =
                $(`<div data-target="${numSlide}" class="slide slide--${numSlide}">
                      <div class="slide__darkbg slide--${numSlide}__darkbg"></div>
                      <div class="slide__text-wrapper slide--${numSlide}__text-wrapper"></div>
                  </div>`);

            const letter =
                $(`<div class="slide__letter slide--${numSlide}__letter">
                      ${firstLetter}
                  </div>`);
            /*
                            for (let i = 0, length = arrCitiesDivided[city].length; i < length; i++) {
                                const text =
                                    $(`<div class="slide__text slide__text--${i + 1}">
                                        ${arrCitiesDivided[city][i]}
                                    </div>`);
                                frag1.append(text);
                            }
            */
            const navSlide = $(`<li data-target="${numSlide}" class="nav__slide nav__slide--${numSlide}"></li>`);
            frag2.append(navSlide);
            $nav.append(frag2);

            $slide.find(`.slide--${numSlide}__text-wrapper`).append(letter).append(frag1);
            $slider.append($slide);

            if (arrCities[city].length <= 4) {
                $('.slide--' + numSlide).find('.slide__text').css("font-size", "12vw");
            }
        };

        for (let i = 0, length = numOfCities; i < length; i++) {
            generateSlide(i);
        }

        $('.nav__slide--1').addClass('nav-active');

        // Navigation
        function bullets(dir) {
            $('.nav__slide--' + curSlide).removeClass('nav-active');
            $('.nav__slide--' + dir).addClass('nav-active');
        }

        function timeout() {
            animation = true;
        }

        function pagination(direction) {
            animation = true;
            diff = 0;
            $slider.addClass('animation');
            $slider.css({
                'transform': 'translate3d(-' + ((curSlide - direction) * 100) + '%, 0, 0)'
            });

            $slider.find('.slide__darkbg').css({
                'transform': 'translate3d(' + ((curSlide - direction) * 50) + '%, 0, 0)'
            });

            $slider.find('.slide__letter').css({
                'transform': 'translate3d(0, 0, 0)',
            });

            $slider.find('.slide__text').css({
                'transform': 'translate3d(0, 0, 0)'
            });
        }

        function navigateRight() {
            if (!autoScrollVar) return;
            if (curSlide >= numOfCities) return;
            pagination(0);
            setTimeout(timeout, animSpd);
            bullets(curSlide + 1);
            curSlide++;
        }

        function navigateLeft() {
            if (curSlide <= 1) return;
            pagination(2);
            setTimeout(timeout, animSpd);
            bullets(curSlide - 1);
            curSlide--;
        }

        function toDefault() {
            pagination(1);
            setTimeout(timeout, animSpd);
        }



        $(document).on('mouseup touchend', function (e) {
            $(document).off('mousemove touchmove');

            if (animation) return;

            if (diff >= distOfLetGo) {
                toDefault();
            } else if (diff <= -distOfLetGo) {
                toDefault();
            } else {
                toDefault();
            }
        });

        $(document).on('click', '.nav__slide:not(.nav-active)', function () {
            let target = +$(this).attr('data-target');
            bullets(target);
            curSlide = target;
            pagination(1);
        });

        $(document).on('click', '.side-nav', function () {
            let target = $(this).attr('data-target');

            if (target === 'right') navigateRight();
            if (target === 'left') navigateLeft();
        });

        $(document).on('keydown', function (e) {
            if (e.which === 39) navigateRight();
            if (e.which === 37) navigateLeft();
        });

        $(document).on('mousewheel DOMMouseScroll', function (e) {
            if (animation) return;
            let delta = e.originalEvent.wheelDelta;

            if (delta > 0 || e.originalEvent.detail < 0) navigateLeft();
            if (delta < 0 || e.originalEvent.detail > 0) navigateRight();
        });
    });
</script>
<script src="{{ url_for('static', filename = 'typing-container.js') }}"></script>
<script>
    const carouselText = [
        { text: "Propose with purpose, implement with passion.", color: "rgba(255, 255, 255, 0.679)" },

    ]

    $(document).ready(async function () {
        carousel(carouselText, "#feature-text")
    });

    async function typeSentence(sentence, eleRef, delay = 100) {
        const letters = sentence.split("");
        let i = 0;
        while (i < letters.length) {
            await waitForMs(delay);
            $(eleRef).append(letters[i]);
            i++;
        }
    }


    async function deleteSentence(eleRef) {
        const sentence = $(eleRef).html();
        const letters = sentence.split("");
        let i = 0;
        while (letters.length > 0) {
            await waitForMs(1000000);
            letters.pop();
            $(eleRef).html(letters.join(""));
        }
    }

    async function carousel(carouselList, eleRef) {
        var i = 0;
        while (true) {
            updateFontColor(eleRef, carouselList[i].color)
            await typeSentence(carouselList[i].text, eleRef);
            await waitForMs(1500);
            await deleteSentence(eleRef);
            await waitForMs(500);
            i++
            if (i >= carouselList.length) { i = 0; }
        }
    }

    function updateFontColor(eleRef, color) {
        $(eleRef).css('color', color);
    }

    function waitForMs(ms) {
        return new Promise(resolve => setTimeout(resolve, ms))
    }
</script>
<script>
    $(function () {
        $('.scroll-down').click(function () {
            $('html, body').animate({ scrollTop: $('section.content').offset().top }, 'slow');
            return false;
        });
    });
</script>

<div id="content">
    <section class="banner-container">
        <div class="cont">
            <div class="slider"></div>
        </div>
        <div class="typing-container" style="top: 50px;">
            <span id="sentence" class="sentence"></span>
            <span id="feature-text" style="font-family: Open Sans, sans-serif;font-weight: bold;font-size: 30px;"></span>
            <span class="input-cursor"></span>
        </div>
        <div class="typing-container" style="margin-top: -270px;
            color: aliceblue;
            /* font-style: unset; */
            font-size: xx-large;
            font-weight: 800;
            letter-spacing: 8px;
            font-size: 110px;
            font-family: inherit;
            align-content: center;
            justify-content: center;
            text-align: center;
            line-height: 120px;"
        >
            Proposed<br>Implementation
            <span id="sentence" class="sentence"></span>
            <span id="feature-text" style="font-family: Open Sans, sans-serif;font-weight: bold;font-size: 30px;"></span>
        </div>
        <a href="#" class="scroll-down" style="margin-bottom: 20px;" address="true"></a>
    </section>
    <section class="content">
        <div class="main-left">
            <div class="sidebar">
                <ul>
                    <li><a id="sidebaritem1" href="#Problem" class="">Overview </a></li>
                    <li><a id="sidebaritem2" href="#Inspiration" class="">Proposed end users</a></li>
                    <button class="sideexpandbutton" id="sideexpandbutton1"></button>
                    <div id="sidebaritem_item1" class="sidebaritem_item-container">
                        <ul>
                            <li class="sidebaritem_item"><a id="" href="#End">End Users of NanoCircDx Colorectal Cancer Screening Platform</a></li>
                            <li class="sidebaritem_item"><a id="Establishment" href="#NanoCircDx">NanoCircDx for Advancing CircRNA Research and Applications</a></li>
                        </ul>
                    </div>
                    <li><a id="sidebaritem3" href="#Our Goal" class="">Validation Through Patient Specimens</a></li>
                    <li><a id="sidebaritem5" href="#Solution" class="">Safety</a></li>
                    <li><a id="sidebaritem5" href="#Reference" class="">Reference</a></li>
                </ul>
            </div>
            <script>
                const sideexpandbutton1 = document.getElementById("sideexpandbutton1");
                const sidebaritem_item1 = document.getElementById("sidebaritem_item1");

                sideexpandbutton1.addEventListener("click", function () {
                    if (sidebaritem_item1.style.display == "none") {
                        sidebaritem_item1.style.display = "block";
                        sideexpandbutton1.style.transform = "rotate(-180deg)";
                    } else {
                        sidebaritem_item1.style.display = "none";
                        sideexpandbutton1.style.transform = "rotate(-360deg)";
                    }
                });
            </script>
        </div>

        <div class="main-right" id="effort">
            <div class="headingbox">
                <h1 class="des-heading1" id="Problem">Overview</h1>
                <button class="expandbutton" id="expandbutton"></button>
            </div>
            <div id="article1" style="display:block;">
                <p class="des-paragraph fade_from_right">
                    While we possess some design
                    prototypes and experimental data for NanoCircDX, there is still a considerable distance to
                    bridge our concepts into real world applications. To bring our innovation into practical use, we
                    must consider various aspects including the proposed end users, envisioning the practical usage
                    of our products, commercialization, entrepreneurship, and safety concerns. This page focuses on
                    the proposed implementation for NanoCircDX, which will target the later stages of our project.
                    We aspire for our product to make a meaningful contribution to society, benefiting the global
                    population.
                </p>
            </div>
            <div class="headingbox">
                <h1 class="des-heading1" id="Inspiration">Proposed end users</h1>
                <button class="expandbutton" id="expandbutton2"></button>
            </div>
            <div id="article2" style="display:block;">
                <h1 class="des-heading2" id="End">
                    <span>&nbsp;&nbsp;&nbsp;&nbsp;</span>End Users of NanoCircDx Colorectal Cancer Screening Platform
                </h1>
                <p class="des-paragraph fade_from_right">
                    NanoCircDx is a novel colorectal
                    cancer screening platform. The developed technology of NanoCircDx not only enables the detection
                    of colorectal cancer but also extends a broader spectrum for the detection of circular RNA
                    (circRNA) through liquid biopsy. Regarding colorectal cancer screening, the most direct end
                    users of our product include individuals who have concerns about or are at the risk of
                    developing the disease. Hospitals and clinics will be the primary institutions offering the
                    cancer screening test developed by NanoCircDx.
                </p>
                <p class="des-paragraph fade_from_right">
                    Given the prevalence of colorectal
                    cancer in Taiwan, particularly among individuals aged 50 and older, the Health Promotion
                    Administration in Taiwan offers subsidies for biennial colorectal cancer screenings to citizens
                    between the ages of 50 and 74 <a href="#[1]">[1]</a>. However, there has been a notable trend of colorectal cancer
                    occurring at younger ages, with an increase in patients aged between 40 and 50 and even
                    individuals in their 30s in recent years <a href="#[2]">[2]</a>. In response to this evolving phenomenon, our team
                    has proposed to integrate NanoCircDx with physical examination. NanoCircDx will be incorporated
                    as an extra choice or listed as an additional option within the blood tests to the general
                    public.
                </p>
                <p class="des-paragraph fade_from_right">
                    Furthermore, with the NanoCircDx
                    colorectal cancer screening platform and our fully automated hardware and software device, we
                    provide a fast and simple detection method without the need of complex and expensive laboratory
                    equipment. This enables the usage of our product in rural and remote health facilities, which
                    can strengthen healthcare for rural communities and enhance medical care networks.
                </p>
                <p class="des-paragraph fade_from_right">
                    To summarize, NanoCircDx's novel
                    colorectal cancer screening platform is positioned for the following target user groups:
                </p>
                <p class="des-paragraph-item fade_from_right">
                    1. Integration of NanoCircDx into hospital and clinic physical examinations.<br>
                    2. Application of the NanoCircDx product in rural and remote healthcare facilities.
                </p>
                <h1 class="des-heading2" id="NanoCircDx">
                    <span>&nbsp;&nbsp;&nbsp;&nbsp;</span>NanoCircDx for Advancing CircRNA Research and Applications
                </h1>
                <p class="des-paragraph fade_from_right">
                    As we develop the detection method
                    of circRNA through liquid biopsy, this idea breaks through current limitations, forging new
                    pathways for the utilization of circRNA. CircRNA, compared to other types of linear RNA,
                    exhibits greater stability, making it not only easier to manipulate but also more suitable for
                    diagnostic purposes. Given that circRNA has not previously served as a direct diagnostic
                    biomarker, our team has pioneered an innovative direct detection protocol for circRNA while
                    establishing a standardized process for circRNA synthesis (<a href="{{ url_for('pages', page='contribution')}}" class="home">linked to contribution</a>). This
                    valuable resource is intended to assist future researchers or iGEM teams in circRNA detection orpage
                    applications.
                </p>
            </div>
            <div class="headingbox">
                <h1 class="des-heading1" id="Our Goal">Validation Through Patient Specimens</h1>
                <button class="expandbutton" id="expandbutton3"></button>
            </div>
            <div id="article3" style="display:block;">
                <p class="des-paragraph fade_from_right">
                     In vitro diagnostics (IVD) are
                    tests used on biological samples such as blood or tissue that have been taken from the human
                    body to determine the status of a person's health <a href="#[3]">[3]</a>. They may also be used in precision
                    medicine to identify patients who are likely to benefit from specific treatments or therapies.
                    Our product, NanoCircDX, falls under the classification of an in vitro diagnostic product.
                </p>
                <p class="des-paragraph fade_from_right">
                    Since the U.S. Food and Drug
                    Administration (FDA) requires Institutional Review Board (IRB) review for all clinical
                    investigations involving human subjects and requests clinical samples with sufficient laboratory
                    or clinical characterization to assess the clinical validity of a new device <a href="#[4]">[4]</a>, including IVDs,
                    this process is an integral part of our product development. Therefore, in September 2023, our
                    team submitted a proposal for the clinical trial application to the Chang Gung Medical
                    Foundation IRB. The proposal, titled “Using highly sensitive gold nanoparticle colorimetric
                    methods and lateral flow reagents to detect highly specific biomarkers of circular ribonucleic
                    acid in the blood of early-stage colorectal cancer patients to assist in colorectal cancer
                    screening”, is currently under review with project number 2309150001.
                </p>
                <p class="des-paragraph fade_from_right">
                    This process aims to access banked
                    specimens from colorectal cancer patients stored in Linkou Chang Gung Memorial Hospital's human
                    biobank for the purpose of conduction of retrospective study. The objective is to validate the
                    laboratory-developed colorectal cancer detection platform, ensuring accurate sensitivity and
                    specificity in detecting colorectal cancer circRNA biomarkers. The proposal requests an
                    assessment of 1,500 frozen specimens for use in the subsequent validation process. These
                    specimens will include 500 cases of individuals with early-stage colorectal cancer (stages I and
                    II), 500 cases of individuals with advanced-stage colorectal cancer (stages III and IV), and 500
                    cases of healthy individuals. All assessed specimens will be randomly assigned to our colorectal
                    cancer detection platform, and a randomized trial will be conducted to prove the clinical
                    effectiveness <a href="#[5]">[5]</a>.
                </p>
                <div class="headingbox">
                <h1 class="des-heading1" id="Our Goal">From Lab to Market </h1>
                <button class="expandbutton" id="expandbutton4"></button>
            </div>
            <div id="article3" style="display:block;">
                <p class="des-paragraph fade_from_right">
                     NanoCircDx is currently in the process of applying for intellectual property and patents as part of our efforts to advance it into a commercially viable medical product. Our primary objective is to bridge the gap between laboratory research and market availability while extending the reach of our product to benefit more patients. This endeavor places a significant emphasis on commercialization and entrepreneurship (<a href="{{ url_for('pages', page='entrepreneurship')}}" class="home">linked to entrepreneurship</a>). 
                </p>
                <p class="des-paragraph fade_from_right">
                     Recognizing the interest of our customers in using our product, we plan to commercialize NanoCircDx by developing it into an easy to use kit. The first step involves skilled nurses and phlebotomists performing blood draws from patients. Subsequently, we will provide a standardized operating procedure for the isolation of circular RNA from blood samples. This critical step must be completed before utilizing our NanoCircDx detection platform. Lastly, our product NanoCircDx will include a user-friendly guide, designed for easy comprehension by the customer. This guide will cover topics such as an introduction to the product, storage and stability information, components of the kit, and a step-by-step user manual. 
                </p>

                <h1 class="des-heading2" id="heading2">
                    <span>&nbsp;&nbsp;&nbsp;&nbsp;</span>Isolation of Circular RNA from Blood Samples
                </h1>
                <p class="des-paragraph fade_from_right">1. Serum Preparation</p>
                <p class="des-paragraph-item fade_from_right">
                    Each participant is required to provide 8 mL of a blood specimen. After collection of the
                    whole blood, allow the blood to clot by leaving it undisturbed at room temperature for 30 minutes,
                    then remove the clot with a refrigerated centrifuge. The resulting supernatant is designated
                    serum. Following centrifugation, serum will be transferred into a clean polypropylene tube,
                    ensuring that sample handling is maintained at 2-8°C. <a href="#[6]">[6]</a><br>
                </p>
                <p class="des-paragraph fade_from_right">2. Exosome Isolation</p>
                <p class="des-paragraph-item fade_from_right">
                    Serum will be combined with ExoQuick exosome precipitation solution (System Bio-Sciences)
                    according to the manufacturer's instructions. The resulting pellet is designated as an exosome. <a href="#[7]">[7]</a><br>
                </p>
                <p class="des-paragraph fade_from_right">3. Exosomal RNA Extraction</p>
                <p class="des-paragraph-item fade_from_right">
                    Total exosomal RNA was extracted from the exosome pellets using the miRNeasy Serum/Serum Kit
                    (Qiagen) according to the supplied protocol. <a href="#[7]">[7]</a><br>
                </p>
                <p class="des-paragraph fade_from_right">4. Ribonuclease R Treatment</p>
                <p class="des-paragraph-item fade_from_right">
                    Ribonuclease R (Thermo Fisher) will be added to the solution
                    after exosomal RNA extraction. Ribonuclease R digests all linear RNAs but does not affect circular
                    RNA structures, thereby increasing the proportion of circular RNA within the specimen.
                </p>
                <h1 class="des-heading2" id="heading2"><span>&nbsp;&nbsp;&nbsp;&nbsp;</span>NanoCircDx User Guide</h1>
                <div style="display: flex;">
                    <iframe
                        src="https://static.igem.wiki/teams/4636/wiki/proposed-implementation/proposed-implementation/proposed-implementation/manual-aunps.pdf"
                        width="50%" height="500px"></iframe>
                    <iframe
                        src="https://static.igem.wiki/teams/4636/wiki/proposed-implementation/proposed-implementation/proposed-implementation/manual-pcrd.pdf"
                        width="50%" height="500px"></iframe>
                </div>
            </div>
            <div class="headingbox">
                <h1 class="des-heading1" id="Solution">Safety</h1>
                <button class="expandbutton" id="expandbutton5"></button>
            </div>
            <div id="article4" style="display:block;">
                <p class="des-paragraph fade_from_right">
                    NanoCircDx is designed as a
                    detection kit with a primary focus on minimizing potential risks associated with its use while
                    maintaining accurate sensitivity and specificity in detecting cancer. To prevent any
                    contamination or mishandling of circRNA samples, it is crucial to ensure proper handling
                    throughout the testing process. To achieve this, we will provide comprehensive and easily
                    understandable instructions and guidelines, emphasizing correct sample handling procedures.
                    Furthermore, all materials utilized in the NanoCircDx kit will be meticulously selected and
                    manufactured to meet stringent quality control standards, aligning with the highest safety
                    requirements. Safety is a fundamental consideration in the development of NanoCircDx, we are
                    dedicated to maintaining the highest safety standards and further ensure the accuracy of our
                    results.
                </p>
                <a class="nav_button" href="{{ url_for('pages', page='safety') }}">
                    <span></span>
                    <span></span>
                    <span></span>
                    <span></span>
                    Click to go Safety!
                </a>
            </div>
            <div id="Reference" style="display:block;">
                <h1 class="des-ref-heading">Reference</h1>
                <p class="des-ref-paragraph">
                    [1] Wang, Y. W., Chen, H. H., Wu, M. S.,
                    Chiu, H. M., & Taiwanese Nationwide Colorectal Cancer Screening Program (2018). Current status
                    and future challenge of population-based organized colorectal cancer screening: Lesson from the
                    first decade of Taiwanese program. <i>Journal of the Formosan Medical Association = Taiwan yi zhi</i>, <b>117</b>(5), 358-364.
                    <a id="[1]" href="https://doi.org/10.1016/j.jfma.2017.09.010">https://doi.org/10.1016/j.jfma.2017.09.010</a>
                </p>
                <p class="des-ref-paragraph">
                    [2] <a id="[2]" href="https://www.hpa.gov.tw/EngPages/Detail.aspx?nodeid=1051&pid=5957">https://www.hpa.gov.tw/EngPages/Detail.aspx?nodeid=1051&pid=5957</a>
                </p>
                <p class="des-ref-paragraph">
                    [3] <a id="[3]" href="https://www.europarl.europa.eu/RegData/etudes/BRIE/2014/542151/EPRS_BRI(2014)542151_REV1_EN.pdf">https://www.europarl.europa.eu/RegData/etudes/BRIE/2014/542151/EPRS_BRI(2014)542151_REV1_EN.pdf</a>
                </p>
                <p class="des-ref-paragraph">
                    [4] <a id="[4]" href="https://www.fda.gov/medical-devices/industry-medical-devices/studies-using-leftover-deidentified-human-specimens-require-irb-review-letter-industry">https://www.fda.gov/medical-devices/industry-medical-devices/studies-using-leftover-deidentified-human-specimens-require-irb-review-letter-industry</a>
                </p>
                <p class="des-ref-paragraph">
                    [5] Minasian, L. M., Pinsky, P., Katki, H.
                    A., Dickherber, T., Han, P. K. J., Harris, L., Patriotis, C., Srivastava, S., Weil, C. J.,
                    Prorok, P. C., & Castle, P. E. (2023). Study design considerations for trials to evaluate
                    multicancer early detection assays for clinical utility. <i>Journal of the National Cancer
                        Institute</i>, <b>115</b>(3), 250-257.<a id="[5]" href=""></a>
                </p>
                <p class="des-ref-paragraph">
                    [6] <a id="[6]" href="https://www.thermofisher.com/tw/zt/home/references/protocols/cell-and-tissue-analysis/elisa-protocol/elisa-sample-preparation-protocols/plasma-and-serum-preparation.html#prot3">https://www.thermofisher.com/tw/zt/home/references/protocols/cell-and-tissue-analysis/elisa-protocol/elisa-sample-preparation-protocols/plasma-and-serum-preparation.html#prot3</a>
                </p>
                <p class="des-ref-paragraph">
                    [7] Xie, Y., Li, J., Li, P., Li, N., Zhang,
                    Y., Binang, H., Zhao, Y., Duan, W., Chen, Y., Wang, Y., Du, L., & Wang, C. (2020). RNA-Seq
                    Profiling of Serum Exosomal Circular RNAs Reveals Circ-PNN as a Potential Biomarker for Human
                    Colorectal Cancer. <i>Frontiers in oncology</i>, <b>10</b>, 982.
                    <a id="[7]" href="https://doi.org/10.3389/fonc.2020.00982">https://doi.org/10.3389/fonc.2020.00982</a>
                </p>
            </div>  
        </div>
        <script src="{{ url_for('static', filename = 'expand-button.js') }}"></script>
    </section>
</div>

{% endblock %}
